Advertisement

Topics

AstraZeneca: Acalabrutinib Gets Breakthrough Therapy Designation From FDA

03:30 EDT 1 Aug 2017 | FinanzNachrichten

LONDON (dpa-AFX) - British drug major AstraZeneca plc. (AZN.L, AZN) and its haematology research and development centre Acerta Pharma announced Tuesday that the US Food and Drug Administration has...

Original Article: AstraZeneca: Acalabrutinib Gets Breakthrough Therapy Designation From FDA

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca: Acalabrutinib Gets Breakthrough Therapy Designation From FDA"

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...